Revolution Medicines, Inc. (RVMD)
USD 31.21
(-5.05%)
USD 31.21
(-5.05%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.08 Billion USD | 157.24% |
| 2022 | 811.93 Million USD | 10.02% |
| 2021 | 737.98 Million USD | 30.06% |
| 2020 | 567.4 Million USD | 157.29% |
| 2019 | 220.52 Million USD | 29.28% |
| 2018 | 170.58 Million USD | 1031.43% |
| 2017 | 15.07 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1.8 Billion USD | -5.24% |
| 2024 Q1 | 1.9 Billion USD | -8.63% |
| 2023 Q3 | 984.23 Million USD | -8.33% |
| 2023 Q2 | 1.07 Billion USD | 0.04% |
| 2023 FY | 2.08 Billion USD | 157.24% |
| 2023 Q1 | 1.07 Billion USD | 32.18% |
| 2023 Q4 | 2.08 Billion USD | 112.21% |
| 2022 Q1 | 632.8 Million USD | -7.32% |
| 2022 FY | 811.93 Million USD | 10.02% |
| 2022 Q4 | 1.07 Billion USD | 32.18% |
| 2022 Q2 | 825.91 Million USD | 30.52% |
| 2022 Q3 | 811.93 Million USD | -1.69% |
| 2021 Q4 | 682.77 Million USD | -7.48% |
| 2021 Q2 | 734.97 Million USD | -5.05% |
| 2021 FY | 737.98 Million USD | 30.06% |
| 2021 Q1 | 774.04 Million USD | -4.63% |
| 2021 Q3 | 737.98 Million USD | 0.41% |
| 2020 Q2 | 595.07 Million USD | 31.09% |
| 2020 Q1 | 453.95 Million USD | -0.08% |
| 2020 FY | 567.4 Million USD | 157.29% |
| 2020 Q4 | 811.65 Million USD | 43.05% |
| 2020 Q3 | 567.4 Million USD | -4.65% |
| 2019 Q2 | 234.74 Million USD | 0.0% |
| 2019 FY | 220.52 Million USD | 29.28% |
| 2019 Q4 | 454.34 Million USD | 106.02% |
| 2019 Q3 | 220.52 Million USD | -6.06% |
| 2018 Q4 | - USD | -100.0% |
| 2018 FY | 170.58 Million USD | 1031.43% |
| 2018 Q3 | 170.58 Million USD | 0.0% |
| 2017 FY | 15.07 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AbCellera Biologics Inc. | 1.48 Billion USD | -40.353% |
| Alkermes plc | 2.13 Billion USD | 2.23% |
| Agenus Inc. | 313.91 Million USD | -565.341% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | 45.466% |
| Aptorum Group Limited | 20.64 Million USD | -10019.098% |
| Ardelyx, Inc. | 297.57 Million USD | -601.861% |
| Arrowhead Pharmaceuticals, Inc. | 765.55 Million USD | -172.822% |
| Bicycle Therapeutics plc | 595.34 Million USD | -250.821% |
| BioXcel Therapeutics, Inc. | 73.7 Million USD | -2733.832% |
| ChromaDex Corporation | 54.96 Million USD | -3699.925% |
| Chimerix, Inc. | 212.77 Million USD | -881.601% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -7287.387% |
| Caribou Biosciences, Inc. | 440.96 Million USD | -373.638% |
| CRISPR Therapeutics AG | 2.22 Billion USD | 6.323% |
| Precision BioSciences, Inc. | 159.78 Million USD | -1207.159% |
| Dyadic International, Inc. | 8.21 Million USD | -25311.011% |
| Eton Pharmaceuticals, Inc. | 31.74 Million USD | -6480.312% |
| Fortress Biotech, Inc. | 167.52 Million USD | -1146.726% |
| Lantern Pharma Inc. | 43.64 Million USD | -4685.12% |
| HOOKIPA Pharma Inc. | 161.33 Million USD | -1194.552% |
| Inhibikase Therapeutics, Inc. | 14.5 Million USD | -14297.476% |
| Incyte Corporation | 6.78 Billion USD | 69.204% |
| IO Biotech, Inc. | 150.71 Million USD | -1285.761% |
| Jaguar Health, Inc. | 50.76 Million USD | -4014.396% |
| Novavax, Inc. | 1.85 Billion USD | -12.572% |
| Janux Therapeutics, Inc. | 380.4 Million USD | -449.041% |
| Opthea Limited | 188.79 Million USD | -1006.297% |
| Ligand Pharmaceuticals Incorporated | 833.06 Million USD | -150.712% |
| ContextLogic Inc. | 423 Million USD | -393.757% |
| MiMedx Group, Inc. | 239.04 Million USD | -773.716% |
| Pyxis Oncology, Inc. | 173.72 Million USD | -1102.233% |
| TransCode Therapeutics, Inc. | 5.16 Million USD | -40300.615% |
| NextCure, Inc. | 129.41 Million USD | -1513.833% |
| Ocuphire Pharma, Inc. | 53.94 Million USD | -3771.489% |
| Oncternal Therapeutics, Inc. | 36.72 Million USD | -5586.49% |
| Outlook Therapeutics, Inc. | 32.3 Million USD | -6366.026% |
| Vaxcyte, Inc. | 1.4 Billion USD | -48.346% |
| PDS Biotechnology Corporation | 59.39 Million USD | -3416.734% |
| Madrigal Pharmaceuticals, Inc. | 640.54 Million USD | -226.064% |
| Pharming Group N.V. | 462.85 Million USD | -351.242% |
| Pieris Pharmaceuticals, Inc. | 38.68 Million USD | -5299.666% |
| Avidity Biosciences, Inc. | 628.55 Million USD | -232.285% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -10936.921% |
| Reviva Pharmaceuticals Holdings, Inc. | 18.92 Million USD | -10936.921% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -1163.363% |
| Sol-Gel Technologies Ltd. | 45.28 Million USD | -4511.9% |
| Acelyrin, Inc. | 742.69 Million USD | -181.22% |
| Salarius Pharmaceuticals, Inc. | 6.58 Million USD | -31610.069% |
| SELLAS Life Sciences Group, Inc. | 6.4 Million USD | -32518.944% |
| Summit Therapeutics Inc. | 202.94 Million USD | -929.121% |
| Sensei Biotherapeutics, Inc. | 74.37 Million USD | -2708.227% |
| Senti Biosciences, Inc. | 119.48 Million USD | -1648.009% |
| Stoke Therapeutics, Inc. | 228.34 Million USD | -814.677% |
| Syros Pharmaceuticals, Inc. | 168.17 Million USD | -1141.923% |
| Alaunos Therapeutics, Inc. | 8.26 Million USD | -25176.425% |
| Telomir Pharmaceuticals, Inc. Common Stock | 4.77 Million USD | -43651.414% |
| Entrada Therapeutics, Inc. | 469.19 Million USD | -345.146% |
| VistaGen Therapeutics, Inc. | 123.65 Million USD | -1589.074% |
| Wave Life Sciences Ltd. | 274.94 Million USD | -659.629% |
| Sorrento Therapeutics, Inc. | 472.84 Million USD | -341.712% |
| TRACON Pharmaceuticals, Inc. | 10.1 Million USD | -20568.887% |
| Barinthus Biotherapeutics plc | 214.5 Million USD | -873.675% |
| Psyence Biomedical Ltd. | 1.13 Million USD | -184378.594% |
| Phathom Pharmaceuticals, Inc. | 413.84 Million USD | -404.683% |
| Immix Biopharma, Inc. | 19.92 Million USD | -10382.179% |
| Keros Therapeutics, Inc. | 370.02 Million USD | -464.446% |
| MEI Pharma, Inc. | 41.37 Million USD | -4947.954% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -6345.075% |
| Xeris Biopharma Holdings, Inc. | 340.79 Million USD | -512.853% |
| Rigel Pharmaceuticals, Inc. | 117.22 Million USD | -1681.694% |
| Fortress Biotech, Inc. | 167.52 Million USD | -1146.726% |
| Precigen, Inc. | 151.04 Million USD | -1282.779% |
| Clearside Biomedical, Inc. | 34.01 Million USD | -6039.664% |
| AlloVir, Inc. | 190.79 Million USD | -994.672% |
| C4 Therapeutics, Inc. | 376.45 Million USD | -454.811% |
| Fate Therapeutics, Inc. | 506.21 Million USD | -312.588% |
| ImmuCell Corporation | 43.8 Million USD | -4667.591% |
| IDEAYA Biosciences, Inc. | 649.31 Million USD | -221.66% |
| Onconetix, Inc. | 88.82 Million USD | -2251.449% |
| PureTech Health plc | 693.97 Million USD | -200.961% |
| VYNE Therapeutics Inc. | 97.68 Million USD | -2038.088% |
| Elevation Oncology, Inc. | 89.09 Million USD | -2244.334% |
| Kintara Therapeutics, Inc. | 6.2 Million USD | -33576.088% |
| Seer, Inc. | 436.26 Million USD | -378.739% |
| Verrica Pharmaceuticals Inc. | 81.59 Million USD | -2459.642% |
| Innoviva, Inc. | 1.24 Billion USD | -67.96% |
| Aadi Bioscience, Inc. | 132.42 Million USD | -1477.212% |
| ESSA Pharma Inc. | 149.12 Million USD | -1300.591% |
| GlycoMimetics, Inc. | 45.31 Million USD | -4508.9% |
| GT Biopharma, Inc. | 14.1 Million USD | -14703.253% |
| Inhibrx Biosciences, Inc. | 307.89 Million USD | -578.35% |
| Akebia Therapeutics, Inc. | 241.7 Million USD | -764.115% |
| Catalyst Pharmaceuticals, Inc. | 471.9 Million USD | -342.585% |
| Longboard Pharmaceuticals, Inc. | 50.69 Million USD | -4019.753% |
| Orchestra BioMed Holdings, Inc. | 95.21 Million USD | -2093.622% |
| Alzamend Neuro, Inc. | 631.58 Thousand USD | -330588.835% |
| Rocket Pharmaceuticals, Inc. | 566.34 Million USD | -268.787% |
| Aptose Biosciences Inc. | 12.92 Million USD | -16062.383% |
| ZyVersa Therapeutics, Inc. | 22.11 Million USD | -9344.534% |
| Soligenix, Inc. | 9.79 Million USD | -21217.97% |
| Century Therapeutics, Inc. | 360.69 Million USD | -479.053% |
| Kura Oncology, Inc. | 448.93 Million USD | -365.232% |
| TScan Therapeutics, Inc. | 272.14 Million USD | -667.444% |
| Intensity Therapeutics, Inc. | 17.29 Million USD | -11976.271% |
| Ocean Biomedical, Inc. | 110.91 Million USD | -1783.118% |
| CytomX Therapeutics, Inc. | 205.15 Million USD | -918.075% |
| Autolus Therapeutics plc | 375.38 Million USD | -456.392% |
| Mineralys Therapeutics, Inc. | 251.63 Million USD | -730.005% |
| EyePoint Pharmaceuticals, Inc. | 355.18 Million USD | -488.031% |
| Eterna Therapeutics Inc. | 49.13 Million USD | -4150.979% |
| Adaptive Biotechnologies Corporation | 661.13 Million USD | -215.91% |
| GRI Bio, Inc. | 2.95 Million USD | -70555.988% |
| Xenetic Biosciences, Inc. | 10.6 Million USD | -19593.979% |
| Tenaya Therapeutics, Inc. | 170.51 Million USD | -1124.872% |
| IGM Biosciences, Inc. | 423.41 Million USD | -393.277% |
| INmune Bio, Inc. | 57 Million USD | -3564.13% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -838.667% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -2388.158% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -7897.099% |
| Entero Therapeutics, Inc. | 6.88 Million USD | -30243.336% |
| Milestone Pharmaceuticals Inc. | 75.22 Million USD | -2676.422% |
| X4 Pharmaceuticals, Inc. | 147.25 Million USD | -1318.321% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -1161.958% |
| Coherus BioSciences, Inc. | 629.6 Million USD | -231.731% |
| Verastem, Inc. | 149.71 Million USD | -1295.017% |
| Abeona Therapeutics Inc. | 64 Million USD | -3163.321% |
| Pliant Therapeutics, Inc. | 512.15 Million USD | -307.805% |
| Tonix Pharmaceuticals Holding Corp. | 154.45 Million USD | -1252.215% |
| Histogen Inc. | 19.07 Million USD | -10850.511% |
| Aprea Therapeutics, Inc. | 22.65 Million USD | -9121.081% |
| Surrozen, Inc. | 46.08 Million USD | -4432.533% |
| Organovo Holdings, Inc. | 6.34 Million USD | -32796.377% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -48374.709% |
| Ovid Therapeutics Inc. | 144.02 Million USD | -1350.141% |
| Panbela Therapeutics, Inc. | 11.8 Million USD | -17596.924% |
| CASI Pharmaceuticals, Inc. | 75.26 Million USD | -2674.872% |
| Cadrenal Therapeutics, Inc. Common Stock | 8.51 Million USD | -24416.137% |
| Centessa Pharmaceuticals plc | 362.96 Million USD | -475.419% |
| Hepion Pharmaceuticals, Inc. | 18.09 Million USD | -11442.75% |
| Arcturus Therapeutics Holdings Inc. | 429.4 Million USD | -386.395% |
| BioRestorative Therapies, Inc. | 12.61 Million USD | -16460.715% |
| Apollomics, Inc. | 55.38 Million USD | -3670.905% |
| Amarin Corporation plc | 831.68 Million USD | -151.128% |
| Mesoblast Limited | 669.15 Million USD | -212.125% |
| Turnstone Biologics Corp. | 112.81 Million USD | -1751.342% |
| Kymera Therapeutics, Inc. | 575.75 Million USD | -262.754% |
| Synaptogenix, Inc. | 31.11 Million USD | -6612.777% |
| Tiziana Life Sciences Ltd | 12.18 Million USD | -17042.08% |
| Aurinia Pharmaceuticals Inc. | 548.06 Million USD | -281.087% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -35467.067% |
| Monopar Therapeutics Inc. | 7.34 Million USD | -28334.932% |
| Exelixis, Inc. | 2.94 Billion USD | 29.016% |
| Better Therapeutics, Inc. | 22.94 Million USD | -9003.391% |
| Nurix Therapeutics, Inc. | 364.53 Million USD | -472.94% |
| Apellis Pharmaceuticals, Inc. | 788.73 Million USD | -164.804% |
| NLS Pharmaceutics AG | 1.84 Million USD | -113002.168% |
| Dermata Therapeutics, Inc. | 7.97 Million USD | -26077.301% |
| Aridis Pharmaceuticals, Inc. | 14.69 Million USD | -14112.936% |
| Gritstone bio, Inc. | 177.76 Million USD | -1074.89% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -2089.758% |
| TNF Pharmaceuticals, Inc. | 17.86 Million USD | -11592.752% |
| Avid Bioservices, Inc. | 336.55 Million USD | -520.576% |
| Insmed Incorporated | 1.32 Billion USD | -57.056% |
| Virpax Pharmaceuticals, Inc. | 9.62 Million USD | -21592.108% |
| MediWound Ltd. | 66.45 Million USD | -3042.676% |
| OmniAb, Inc. | 401.98 Million USD | -419.569% |
| Alector, Inc. | 621.82 Million USD | -235.88% |
| Seres Therapeutics, Inc. | 358.6 Million USD | -482.429% |
| Checkpoint Therapeutics, Inc. | 5.37 Million USD | -38735.831% |
| Viracta Therapeutics, Inc. | 56.69 Million USD | -3584.102% |
| Zai Lab Limited | 1.03 Billion USD | -101.544% |
| Revance Therapeutics, Inc. | 478.45 Million USD | -336.529% |
| Aura Biosciences, Inc. | 255.07 Million USD | -718.814% |
| Lyell Immunopharma, Inc. | 750.02 Million USD | -178.468% |
| Immunic, Inc. | 54.29 Million USD | -3746.463% |
| Tarsus Pharmaceuticals, Inc. | 266.22 Million USD | -684.524% |
| Veracyte, Inc. | 1.13 Billion USD | -83.561% |
| InMed Pharmaceuticals Inc. | 11.82 Million USD | -17565.817% |
| FibroGen, Inc. | 423.52 Million USD | -393.14% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -59353.202% |
| Adial Pharmaceuticals, Inc. | 4.73 Million USD | -43994.684% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.42 Million USD | -38367.621% |
| Jazz Pharmaceuticals plc | 11.39 Billion USD | 81.668% |
| Cyclacel Pharmaceuticals, Inc. | 8.8 Million USD | -23620.511% |
| Amylyx Pharmaceuticals, Inc. | 517.45 Million USD | -303.628% |
| TG Therapeutics, Inc. | 329.58 Million USD | -533.699% |
| Galecto, Inc. | 38.22 Million USD | -5363.654% |
| Calithera Biosciences, Inc. | 28.67 Million USD | -7183.411% |
| Fortrea Holdings Inc. | 4.35 Billion USD | 52.066% |
| KalVista Pharmaceuticals, Inc. | 235.4 Million USD | -787.237% |
| Aptevo Therapeutics Inc. | 24.84 Million USD | -8307.499% |
| XBiotech Inc. | 227.24 Million USD | -819.1% |
| Jasper Therapeutics, Inc. | 95.38 Million USD | -2089.758% |
| Lyra Therapeutics, Inc. | 142.6 Million USD | -1364.65% |
| Foghorn Therapeutics Inc. | 285.91 Million USD | -630.491% |
| Y-mAbs Therapeutics, Inc. | 127.86 Million USD | -1533.383% |
| Theravance Biopharma, Inc. | 381.99 Million USD | -446.753% |
| Ultragenyx Pharmaceutical Inc. | 1.49 Billion USD | -40.079% |
| Metagenomi, Inc. Common Stock | 364.84 Million USD | -472.465% |
| Vaxxinity, Inc. | 44.35 Million USD | -4609.019% |
| BioCryst Pharmaceuticals, Inc. | 516.96 Million USD | -304.014% |
| Gain Therapeutics, Inc. | 18.6 Million USD | -11123.353% |
| Cartesian Therapeutics, Inc. | 305.05 Million USD | -584.672% |
| NexImmune, Inc. | 8.59 Million USD | -24203.042% |
| Creative Medical Technology Holdings, Inc. | 10.71 Million USD | -19391.871% |
| Marker Therapeutics, Inc. | 17.12 Million USD | -12094.449% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | 93.686% |
| Chemomab Therapeutics Ltd. | 22.15 Million USD | -9328.823% |
| Scopus BioPharma Inc. | 392.26 Thousand USD | -532343.884% |
| RAPT Therapeutics, Inc. | 173.32 Million USD | -1104.986% |
| Ainos, Inc. | 31.84 Million USD | -6459.273% |
| Pluri Inc. | 39.52 Million USD | -5183.96% |
| Prothena Corporation plc | 696.38 Million USD | -199.92% |
| Adaptimmune Therapeutics plc | 282.61 Million USD | -639.021% |
| Celularity Inc. | 143.88 Million USD | -1351.529% |
| Rallybio Corporation | 115.62 Million USD | -1706.427% |
| Cue Biopharma, Inc. | 61.53 Million USD | -3294.427% |
| MeiraGTx Holdings plc | 458.16 Million USD | -355.857% |
| Omeros Corporation | 378.26 Million USD | -452.144% |
| Humacyte, Inc. | 128.22 Million USD | -1528.874% |
| Immunocore Holdings plc | 597 Million USD | -249.847% |
| Cocrystal Pharma, Inc. | 31.25 Million USD | -6581.567% |
| Cidara Therapeutics, Inc. | 68.53 Million USD | -2947.703% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -99.056% |
| CalciMedica, Inc. | 12.18 Million USD | -17040.673% |
| Cabaletta Bio, Inc. | 253.65 Million USD | -723.415% |
| Marinus Pharmaceuticals, Inc. | 170.9 Million USD | -1122.056% |
| Scholar Rock Holding Corporation | 311.03 Million USD | -571.497% |
| Sana Biotechnology, Inc. | 565.29 Million USD | -269.467% |
| Pulmatrix, Inc. | 33.95 Million USD | -6050.512% |
| Elicio Therapeutics, Inc. | 27.14 Million USD | -7593.918% |
| Vigil Neuroscience, Inc. | 140.85 Million USD | -1382.763% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -60.54% |
| Adlai Nortye Ltd. American Depositary Shares | 130.18 Million USD | -1504.276% |
| Cytokinetics, Incorporated | 824.31 Million USD | -153.373% |
| Eloxx Pharmaceuticals, Inc. | 21.12 Million USD | -9787.757% |
| Nutriband Inc. | 7.51 Million USD | -27684.332% |
| Protara Therapeutics, Inc. | 78.95 Million USD | -2545.326% |
| Vor Biopharma Inc. | 209.82 Million USD | -895.382% |
| Roivant Sciences Ltd. | 7.22 Billion USD | 71.082% |
| Evogene Ltd. | 51.1 Million USD | -3987.182% |
| ProKidney Corp. | 420.55 Million USD | -396.631% |
| Applied Therapeutics, Inc. | 54.83 Million USD | -3709.004% |
| Hoth Therapeutics, Inc. | 9.52 Million USD | -21838.34% |
| BridgeBio Pharma, Inc. | 546.38 Million USD | -282.26% |
| CorMedix Inc. | 82.05 Million USD | -2445.201% |
| BioLineRx Ltd. | 63.92 Million USD | -3167.252% |
| Tango Therapeutics, Inc. | 402.56 Million USD | -418.818% |
| Galectin Therapeutics Inc. | 28.2 Million USD | -7306.351% |
| Atai Life Sciences N.V. | 293.47 Million USD | -611.669% |
| Renovaro Biosciences Inc. | 163.12 Million USD | -1180.327% |
| Aerovate Therapeutics, Inc. | 127.41 Million USD | -1539.165% |
| Zentalis Pharmaceuticals, Inc. | 562.02 Million USD | -271.618% |
| Sagimet Biosciences Inc. | 96.71 Million USD | -2059.442% |
| MediciNova, Inc. | 66.26 Million USD | -3051.64% |
| Praxis Precision Medicines, Inc. | 87.94 Million USD | -2274.802% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -46704.576% |
| GeoVax Labs, Inc. | 9.28 Million USD | -22398.564% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -255.06% |
| Biomea Fusion, Inc. | 199.92 Million USD | -944.677% |
| PTC Therapeutics, Inc. | 1.9 Billion USD | -9.742% |
| Mereo BioPharma Group plc | 66.49 Million USD | -3040.786% |
| Cullinan Oncology, Inc. | 485.09 Million USD | -330.552% |
| Syndax Pharmaceuticals, Inc. | 612.88 Million USD | -240.783% |
| Absci Corporation | 234.48 Million USD | -790.733% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -28452.167% |
| 4D Molecular Therapeutics, Inc. | 339.89 Million USD | -514.488% |
| Dyne Therapeutics, Inc. | 165.08 Million USD | -1165.184% |
| Kiniksa Pharmaceuticals, Ltd. | 526.32 Million USD | -296.828% |
| Ventyx Biosciences, Inc. | 277.69 Million USD | -652.122% |
| Allakos Inc. | 243.61 Million USD | -757.35% |
| Imunon, Inc. | 21.91 Million USD | -9429.083% |
| Fulcrum Therapeutics, Inc. | 257.69 Million USD | -710.493% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -236.047% |
| BioAtla, Inc. | 119.65 Million USD | -1645.467% |
| NLS Pharmaceutics AG | 1.84 Million USD | -113002.168% |
| Bio-Path Holdings, Inc. | 3.22 Million USD | -64763.075% |
| Allogene Therapeutics, Inc. | 642.83 Million USD | -224.902% |
| Larimar Therapeutics, Inc. | 95.93 Million USD | -2077.09% |
| XOMA Corporation | 234.3 Million USD | -791.414% |
| Kezar Life Sciences, Inc. | 221.23 Million USD | -844.06% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -1559.667% |
| aTyr Pharma, Inc. | 122.06 Million USD | -1611.02% |
| Aligos Therapeutics, Inc. | 153.9 Million USD | -1257.083% |
| Akero Therapeutics, Inc. | 580.27 Million USD | -259.934% |
| Viridian Therapeutics, Inc. | 490.42 Million USD | -325.875% |
| Eliem Therapeutics, Inc. | 110.46 Million USD | -1790.658% |
| EyeGate Pharmaceuticals, Inc. | 15.15 Million USD | -13679.204% |
| Akari Therapeutics, Plc | 4.35 Million USD | -47858.462% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -12158.908% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -20.5% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -67623.751% |
| UroGen Pharma Ltd. | 178.31 Million USD | -1071.319% |
| Sutro Biopharma, Inc. | 470.73 Million USD | -343.686% |
| ZIVO Bioscience, Inc. | 555.71 Thousand USD | -375738.514% |
| Orgenesis Inc. | 14.55 Million USD | -14252.604% |
| Entera Bio Ltd. | 11.76 Million USD | -17652.58% |
| GH Research PLC | 226.3 Million USD | -822.93% |
| Lisata Therapeutics, Inc. | 54.69 Million USD | -3718.684% |
| Reneo Pharmaceuticals, Inc. | 107.43 Million USD | -1844.033% |
| Xencor, Inc. | 952.69 Million USD | -119.23% |
| 60 Degrees Pharmaceuticals, Inc. | 7.78 Million USD | -26732.637% |
| Replimune Group, Inc. | 487.72 Million USD | -328.234% |
| Coeptis Therapeutics Holdings, Inc. | 8.07 Million USD | -25777.437% |
| Vanda Pharmaceuticals Inc. | 648.44 Million USD | -222.095% |
| Lexaria Bioscience Corp. | 3.08 Million USD | -67623.751% |
| Portage Biotech Inc. | 7.77 Million USD | -26749.094% |
| Cardio Diagnostics Holdings, Inc. | 4.46 Million USD | -46704.576% |
| Olema Pharmaceuticals, Inc. | 276.94 Million USD | -654.154% |
| OncoCyte Corporation | 74.89 Million USD | -2688.804% |
| Qualigen Therapeutics, Inc. | 2.03 Million USD | -102621.901% |
| Processa Pharmaceuticals, Inc. | 5.78 Million USD | -35993.31% |
| Purple Biotech Ltd. | 44.3 Million USD | -4614.44% |
| CollPlant Biotechnologies Ltd. | 34.12 Million USD | -6020.234% |
| scPharmaceuticals Inc. | 94.47 Million USD | -2110.64% |
| ProMIS Neurosciences, Inc. | 18.04 Million USD | -11474.374% |
| HilleVax, Inc. | 344.43 Million USD | -506.384% |
| NeuroSense Therapeutics Ltd. | 3.17 Million USD | -65661.681% |
| Tharimmune, Inc. | 10.94 Million USD | -18980.176% |
| Genprex, Inc. | 10.67 Million USD | -19473.338% |
| Neumora Therapeutics, Inc. Common Stock | 496.19 Million USD | -320.921% |
| Atossa Therapeutics, Inc. | 96.25 Million USD | -2069.92% |
| XTL Biopharmaceuticals Ltd. | 2.42 Million USD | -85991.962% |
| Virios Therapeutics, Inc. | 4.16 Million USD | -50040.933% |
| OKYO Pharma Limited | 1.54 Million USD | -135411.567% |
| Savara Inc. | 177.56 Million USD | -1076.247% |
| Curis, Inc. | 77.28 Million USD | -2602.558% |
| Daré Bioscience, Inc. | 21.28 Million USD | -9713.786% |
| Carmell Therapeutics Corporation | 63.94 Million USD | -3166.036% |
| Titan Pharmaceuticals, Inc. | 8.08 Million USD | -25729.718% |
| Achieve Life Sciences, Inc. | 19.37 Million USD | -10682.05% |
| BeiGene, Ltd. | 5.8 Billion USD | 64.023% |
| Kiromic BioPharma, Inc. | 12.16 Million USD | -17063.21% |
| Revolution Medicines, Inc. Warrant | 2.08 Billion USD | 0.0% |
| Protagonist Therapeutics, Inc. | 357.95 Million USD | -483.485% |
| Erasca, Inc. | 395.29 Million USD | -428.36% |
| bluebird bio, Inc. | 619.16 Million USD | -237.326% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -48209.339% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | 69.472% |
| DBV Technologies S.A. | 182.98 Million USD | -1041.394% |
| Protagenic Therapeutics, Inc. | 4.32 Million USD | -48209.339% |
| Moderna, Inc. | 18.42 Billion USD | 88.665% |
| Vincerx Pharma, Inc. | 18.21 Million USD | -11365.066% |
| Fresh Tracks Therapeutics, Inc. | 11.58 Million USD | -17926.851% |
| Molecular Templates, Inc. | 35.38 Million USD | -5802.809% |
| Acrivon Therapeutics, Inc. Common Stock | 138.26 Million USD | -1410.571% |
| Travere Therapeutics, Inc. | 788.91 Million USD | -164.743% |
| Monte Rosa Therapeutics, Inc. | 303.75 Million USD | -587.591% |
| Spruce Biosciences, Inc. | 103.94 Million USD | -1909.304% |
| Celldex Therapeutics, Inc. | 465.62 Million USD | -348.555% |
| Cogent Biosciences, Inc. | 313.43 Million USD | -566.351% |
| MacroGenics, Inc. | 306.82 Million USD | -580.722% |
| RenovoRx, Inc. | 1.46 Million USD | -142368.69% |
| Adicet Bio, Inc. | 207.29 Million USD | -907.545% |
| Prime Medicine, Inc. | 193.85 Million USD | -977.421% |
| Aditxt, Inc. | 44.57 Million USD | -4585.216% |
| Adagene Inc. | 115.72 Million USD | -1704.728% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -46790.489% |
| Quantum-Si incorporated | 298.25 Million USD | -600.282% |
| Maravai LifeSciences Holdings, Inc. | 1.48 Billion USD | -40.414% |
| Acurx Pharmaceuticals, Inc. | 7.7 Million USD | -26992.459% |
| Voyager Therapeutics, Inc. | 351.28 Million USD | -494.564% |
| SciSparc Ltd. | 11.18 Million USD | -18578.152% |
| Vericel Corporation | 353.65 Million USD | -490.57% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -17001.923% |
| Minerva Neurosciences, Inc. | 56.9 Million USD | -3570.595% |
| Generation Bio Co. | 374.75 Million USD | -457.317% |
| Astria Therapeutics, Inc. | 254.66 Million USD | -720.13% |
| Black Diamond Therapeutics, Inc. | 158.56 Million USD | -1217.166% |
| Arcutis Biotherapeutics, Inc. | 341.36 Million USD | -511.835% |
| Invivyd, Inc. | 229.18 Million USD | -811.328% |
| Relay Therapeutics, Inc. | 843.98 Million USD | -147.469% |
| Quoin Pharmaceuticals, Ltd. | 12.16 Million USD | -17062.785% |
| Spero Therapeutics, Inc. | 182.39 Million USD | -1045.124% |
| Artelo Biosciences, Inc. | 20.42 Million USD | -10126.16% |
| 2seventy bio, Inc. | 565.42 Million USD | -269.384% |
| ADMA Biologics, Inc. | 329.18 Million USD | -534.479% |
| Clene Inc. | 52.34 Million USD | -3890.354% |
| Capricor Therapeutics, Inc. | 58.73 Million USD | -3455.997% |
| Boundless Bio, Inc. Common Stock | 129.89 Million USD | -1507.92% |
| GeoVax Labs, Inc. | 9.28 Million USD | -22398.564% |
| Recursion Pharmaceuticals, Inc. | 653.69 Million USD | -219.503% |
| Citius Pharmaceuticals, Inc. | 103.61 Million USD | -1915.798% |
| Contineum Therapeutics, Inc. Class A Common Stock | 130.38 Million USD | -1501.852% |
| Relmada Therapeutics, Inc. | 97.55 Million USD | -2041.002% |
| Finch Therapeutics Group, Inc. | 70.99 Million USD | -2841.802% |
| ALX Oncology Holdings Inc. | 242.55 Million USD | -761.086% |
| Vir Biotechnology, Inc. | 1.96 Billion USD | -6.556% |
| Evaxion Biotech A/S | 12.88 Million USD | -16104.925% |
| Ocular Therapeutix, Inc. | 252.06 Million USD | -728.609% |
| Verve Therapeutics, Inc. | 752.68 Million USD | -177.484% |
| Trevena, Inc. | 40.6 Million USD | -5043.679% |
| Surrozen, Inc. | 46.08 Million USD | -4432.533% |
| Tyra Biosciences, Inc. | 225.85 Million USD | -824.74% |
| Cingulate Inc. | 3.49 Million USD | -59720.401% |
| Galmed Pharmaceuticals Ltd. | 16.62 Million USD | -12459.931% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -3079.466% |
| Tenax Therapeutics, Inc. | 11.68 Million USD | -17774.691% |
| Terns Pharmaceuticals, Inc. | 268.51 Million USD | -677.824% |
| ACADIA Pharmaceuticals Inc. | 748.95 Million USD | -178.867% |
| Connect Biopharma Holdings Limited | 125.89 Million USD | -1559.034% |
| Clearmind Medicine Inc. | 4.32 Million USD | -48197.945% |
| Kronos Bio, Inc. | 213.27 Million USD | -879.276% |
| Bolt Biotherapeutics, Inc. | 159.78 Million USD | -1207.134% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -24297.689% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -466.797% |
| Statera Biopharma, Inc. | 21.16 Million USD | -9765.952% |
| ImmunityBio, Inc. | 504.45 Million USD | -314.032% |
| Korro Bio, Inc. | 221.66 Million USD | -842.237% |
| Kineta, Inc. | 10.28 Million USD | -20215.057% |
| BioVie Inc. | 25.2 Million USD | -8185.316% |
| Codexis, Inc. | 136.56 Million USD | -1429.42% |
| Celularity Inc. | 143.88 Million USD | -1351.529% |
| Crinetics Pharmaceuticals, Inc. | 635.35 Million USD | -228.729% |
| Celcuity Inc. | 191.21 Million USD | -992.248% |
| Virax Biolabs Group Limited | 5.48 Million USD | -37985.39% |
| Cibus, Inc. | 544.41 Million USD | -283.642% |
| Eledon Pharmaceuticals, Inc. | 125.89 Million USD | -1559.008% |
| eFFECTOR Therapeutics, Inc. | 20.54 Million USD | -10066.428% |
| IN8bio, Inc. | 33.7 Million USD | -6095.945% |
| Kodiak Sciences Inc. | 479.37 Million USD | -335.693% |
| Annexon, Inc. | 297.67 Million USD | -601.637% |
| Adverum Biotechnologies, Inc. | 173.01 Million USD | -1107.208% |
| Assembly Biosciences, Inc. | 137.46 Million USD | -1419.318% |
| Avalo Therapeutics, Inc. | 20.99 Million USD | -9848.988% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | 30.149% |
| Eyenovia, Inc. | 28.77 Million USD | -7157.25% |
| Puma Biotechnology, Inc. | 230.52 Million USD | -806.003% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -28811.836% |
| Xilio Therapeutics, Inc. | 60.92 Million USD | -3328.078% |
| Arcellx, Inc. | 825.13 Million USD | -153.122% |
| Cardiff Oncology, Inc. | 81.63 Million USD | -2458.388% |
| Enanta Pharmaceuticals, Inc. | 462.27 Million USD | -351.807% |
| Regulus Therapeutics Inc. | 30.75 Million USD | -6692.166% |
| Moolec Science SA | 24.05 Million USD | -8583.905% |
| Acumen Pharmaceuticals, Inc. | 310.12 Million USD | -573.467% |
| Geron Corporation | 394.07 Million USD | -429.997% |
| LAVA Therapeutics N.V. | 101.71 Million USD | -1953.477% |
| Royalty Pharma plc | 16.38 Billion USD | 87.251% |
| Atea Pharmaceuticals, Inc. | 594.96 Million USD | -251.043% |
| Greenwich LifeSciences, Inc. | 6.99 Million USD | -29759.131% |
| TFF Pharmaceuticals, Inc. | 12.02 Million USD | -17265.396% |
| Mersana Therapeutics, Inc. | 226.06 Million USD | -823.91% |
| Humacyte, Inc. | 128.22 Million USD | -1528.874% |
| Structure Therapeutics Inc. | 482.01 Million USD | -333.302% |
| 89bio, Inc. | 596.26 Million USD | -250.277% |
| PMV Pharmaceuticals, Inc. | 252.15 Million USD | -728.306% |
| Avenue Therapeutics, Inc. | 1.85 Million USD | -112796.811% |
| Genelux Corporation | 27.89 Million USD | -7387.868% |
| Trevi Therapeutics, Inc. | 89.4 Million USD | -2236.153% |
| Lexicon Pharmaceuticals, Inc. | 229.42 Million USD | -810.343% |
| Notable Labs, Ltd. | 19.54 Million USD | -10588.25% |
| Liquidia Corporation | 120.43 Million USD | -1634.264% |
| Mustang Bio, Inc. | 17.74 Million USD | -11672.016% |
| Immunovant, Inc. | 666.71 Million USD | -213.267% |
| Quantum-Si incorporated | 298.25 Million USD | -600.282% |
| Arbutus Biopharma Corporation | 144.4 Million USD | -1346.383% |
| DiaMedica Therapeutics Inc. | 54.16 Million USD | -3756.335% |
| Vera Therapeutics, Inc. | 175.54 Million USD | -1089.768% |
| Acasti Pharma Inc. | 73.3 Million USD | -2749.374% |
| MiNK Therapeutics, Inc. | 4.55 Million USD | -45780.098% |
| Pasithea Therapeutics Corp. | 26.11 Million USD | -7897.099% |
| Xenon Pharmaceuticals Inc. | 964.79 Million USD | -116.48% |
| Elevai Labs, Inc. Common Stock | 5.18 Million USD | -40143.237% |
| NeuroBo Pharmaceuticals, Inc. | 22.78 Million USD | -9068.127% |
| Tempest Therapeutics, Inc. | 51.6 Million USD | -3947.422% |
| Soleno Therapeutics, Inc. | 180.69 Million USD | -1055.891% |
| PepGen Inc. | 143.05 Million USD | -1360.022% |
| Moleculin Biotech, Inc. | 38.21 Million USD | -5365.084% |
| United Therapeutics Corporation | 7.16 Billion USD | 70.858% |
| Nuvectis Pharma, Inc. | 19.18 Million USD | -10786.583% |
| Solid Biosciences Inc. | 164.93 Million USD | -1166.281% |
| BriaCell Therapeutics Corp. | 5.87 Million USD | -35467.067% |
| Immuneering Corporation | 102.58 Million USD | -1935.971% |
| Lixte Biotechnology Holdings, Inc. | 4.3 Million USD | -48374.709% |
| Silo Pharma, Inc. | 7.74 Million USD | -26862.987% |
| Belite Bio, Inc | 94.64 Million USD | -2106.833% |
| XOMA Corporation | 234.3 Million USD | -791.414% |
| ARS Pharmaceuticals, Inc. | 233.18 Million USD | -795.668% |
| Bionomics Limited | 27.64 Million USD | -7453.922% |
| Apogee Therapeutics, Inc. | 401.4 Million USD | -420.321% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -1844.902% |
| uniQure N.V. | 831.68 Million USD | -151.126% |
| Cassava Sciences, Inc. | 151.66 Million USD | -1277.126% |
| Estrella Immunopharma, Inc. | 4.45 Million USD | -46790.489% |
| Poseida Therapeutics, Inc. | 273.88 Million USD | -662.58% |
| Forte Biosciences, Inc. | 38.98 Million USD | -5258.109% |
| Anebulo Pharmaceuticals, Inc. | 4.07 Million USD | -51177.499% |
| Enlivex Therapeutics Ltd. | 36.83 Million USD | -5570.742% |
| Conduit Pharmaceuticals Inc. | 7.22 Million USD | -28811.836% |
| SeaStar Medical Holding Corporation | 3.51 Million USD | -59353.202% |
| FibroBiologics, Inc. Common Stock | 11.82 Million USD | -17568.48% |
| Altimmune, Inc. | 210.64 Million USD | -891.545% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -168.498% |
| Alpha Tau Medical Ltd. | 107.38 Million USD | -1844.902% |
| Compugen Ltd. | 121.33 Million USD | -1621.357% |
| Peak Bio, Inc. | 2.59 Million USD | -80341.339% |
| Zevra Therapeutics, Inc. | 172.32 Million USD | -1111.993% |
| Benitec Biopharma Inc. | 52.21 Million USD | -3900.366% |
| Spyre Therapeutics, Inc. | 341.85 Million USD | -510.951% |
| NKGen Biotech, Inc. Common Stock | 34.77 Million USD | -5906.358% |
| Zura Bio Limited | 100.84 Million USD | -1971.131% |
| PolyPid Ltd. | 15.37 Million USD | -13486.983% |
| Aileron Therapeutics, Inc. | 119.28 Million USD | -1650.91% |
| NKGen Biotech, Inc. Warrants | 34.77 Million USD | -5906.358% |
| Instil Bio, Inc. | 325.63 Million USD | -541.4% |
| argenx SE | 4.54 Billion USD | 54.021% |
| Immunome, Inc. | 148.54 Million USD | -1306.08% |
| Compass Therapeutics, Inc. | 156.87 Million USD | -1231.373% |
| Verona Pharma plc | 308.12 Million USD | -577.841% |
| enGene Holdings Inc. Warrants | 86.95 Million USD | -2301.811% |
| Shattuck Labs, Inc. | 159.56 Million USD | -1208.936% |
| CervoMed Inc. | 9.97 Million USD | -20843.461% |
| LENZ Therapeutics, Inc. | 188.45 Million USD | -1008.265% |
| Plus Therapeutics, Inc. | 11.38 Million USD | -18240.279% |
| Dianthus Therapeutics, Inc. | 179.4 Million USD | -1064.177% |
| Moolec Science SA | 24.05 Million USD | -8583.905% |
| Enveric Biosciences, Inc. | 6.11 Million USD | -34041.362% |
| Inovio Pharmaceuticals, Inc. | 172.94 Million USD | -1107.666% |
| AnaptysBio, Inc. | 452.38 Million USD | -361.68% |
| Design Therapeutics, Inc. | 289.64 Million USD | -621.091% |
| Leap Therapeutics, Inc. | 72.82 Million USD | -2767.959% |
| NeurAxis, Inc. | 509.49 Thousand USD | -409831.148% |
| Seelos Therapeutics, Inc. | 5.41 Million USD | -38449.114% |
| Lumos Pharma, Inc. | 40.63 Million USD | -5039.502% |
| Achilles Therapeutics plc | 161.45 Million USD | -1193.598% |
| enGene Holdings Inc. Common Stock | 86.95 Million USD | -2301.811% |
| 180 Life Sciences Corp. | 5.25 Million USD | -39611.009% |
| Opiant Pharmaceuticals, Inc. | 70.42 Million USD | -2865.578% |
| CERo Therapeutics Holdings, Inc. | 8.56 Million USD | -24297.689% |
| Nutriband Inc. | 7.51 Million USD | -27684.332% |
| ORIC Pharmaceuticals, Inc. | 254.68 Million USD | -720.065% |
| CG Oncology, Inc. Common stock | 199.3 Million USD | -947.958% |
| Fractyl Health, Inc. Common Stock | 76.21 Million USD | -2640.501% |
| Rani Therapeutics Holdings, Inc. | 57.91 Million USD | -3506.242% |
| MoonLake Immunotherapeutics | 526.54 Million USD | -296.663% |
| Palisade Bio, Inc. | 14.05 Million USD | -14763.301% |
| Tourmaline Bio, Inc. | 210.29 Million USD | -893.172% |
| Beam Therapeutics Inc. | 1.45 Billion USD | -43.082% |
| Neurogene Inc. | 222.57 Million USD | -838.385% |
| Mirum Pharmaceuticals, Inc. | 646.62 Million USD | -223.001% |
| AEON Biopharma, Inc. | 6.84 Million USD | -30412.652% |
| CARGO Therapeutics, Inc. Common Stock | 453.03 Million USD | -361.021% |
| Sesen Bio, Inc. | 189.17 Million USD | -1004.058% |
| Enliven Therapeutics, Inc. | 271.86 Million USD | -668.24% |
| Kiora Pharmaceuticals, Inc. | 13.71 Million USD | -15131.992% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -167.648% |
| Taysha Gene Therapies, Inc. | 266.99 Million USD | -682.261% |
| Athira Pharma, Inc. | 160.24 Million USD | -1203.374% |
| Vaccinex, Inc. | 3.63 Million USD | -57421.096% |
| HCW Biologics Inc. | 28.51 Million USD | -7224.879% |
| XOMA Corporation | 234.3 Million USD | -791.414% |
| Nektar Therapeutics | 398.03 Million USD | -424.728% |
| Arvinas, Inc. | 1.3 Billion USD | -60.094% |
| Tevogen Bio Holdings Inc. | 17.03 Million USD | -12158.908% |
| Merus N.V. | 458.49 Million USD | -355.533% |
| Omega Therapeutics, Inc. | 204.36 Million USD | -921.986% |
| Quince Therapeutics, Inc. | 180.2 Million USD | -1059.015% |
| Rezolute, Inc. | 132.73 Million USD | -1473.481% |
| Clene Inc. | 52.34 Million USD | -3890.354% |
| Indaptus Therapeutics, Inc. | 14.92 Million USD | -13894.962% |
| BeyondSpring Inc. | 24.8 Million USD | -8319.022% |
| Synlogic, Inc. | 75.55 Million USD | -2664.515% |
| Allarity Therapeutics, Inc. | 11.86 Million USD | -17507.41% |
| Phio Pharmaceuticals Corp. | 9.36 Million USD | -22204.475% |
| Peak Bio, Inc. | 2.59 Million USD | -80341.339% |
| Werewolf Therapeutics, Inc. | 174.83 Million USD | -1094.621% |
| Krystal Biotech, Inc. | 818.35 Million USD | -155.218% |
| Karyopharm Therapeutics Inc. | 240.43 Million USD | -768.661% |
| SpringWorks Therapeutics, Inc. | 725.78 Million USD | -187.769% |
| Lipella Pharmaceuticals Inc. | 3.57 Million USD | -58286.62% |
| MannKind Corporation | 475.19 Million USD | -339.52% |
| Ikena Oncology, Inc. | 192.09 Million USD | -987.287% |
| Cyclerion Therapeutics, Inc. | 13.37 Million USD | -15516.801% |
| Gyre Therapeutics, Inc. | 116.53 Million USD | -1692.182% |
| Gossamer Bio, Inc. | 311.91 Million USD | -569.6% |
| CohBar, Inc. | 16.36 Million USD | -12662.028% |
| Cognition Therapeutics, Inc. | 35.16 Million USD | -5839.741% |
| NRx Pharmaceuticals, Inc. | 7.31 Million USD | -28452.167% |
| Legend Biotech Corporation | 1.84 Billion USD | -12.982% |
| Mural Oncology plc | 301.74 Million USD | -592.171% |
| Biora Therapeutics, Inc. | 31.21 Million USD | -6590.985% |
| PaxMedica, Inc. Common Stock | 5.68 Million USD | -36668.347% |
| Disc Medicine, Inc. | 367.99 Million USD | -467.558% |
| Champions Oncology, Inc. | 26.13 Million USD | -7892.465% |
| REGENXBIO Inc. | 573.97 Million USD | -263.885% |
| Ensysce Biosciences, Inc. | 2.7 Million USD | -77024.278% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -1252.837% |
| Cellectar Biosciences, Inc. | 12.07 Million USD | -17195.989% |
| Edgewise Therapeutics, Inc. | 340.03 Million USD | -514.228% |
| Vaxart, Inc. | 91.83 Million USD | -2174.41% |
| PharmaCyte Biotech, Inc. | 59.9 Million USD | -3386.57% |
| Aldeyra Therapeutics, Inc. | 148.32 Million USD | -1308.1% |
| Cellectis S.A. | 334.27 Million USD | -524.822% |
| Longeveron Inc. | 12.17 Million USD | -17050.526% |
| Repare Therapeutics Inc. | 253.9 Million USD | -722.601% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | 36.023% |
| Inozyme Pharma, Inc. | 200.84 Million USD | -939.892% |
| Nymox Pharmaceutical Corporation | 1.62 Million USD | -128428.677% |
| Third Harmonic Bio, Inc. | 277.71 Million USD | -652.074% |
| ArriVent BioPharma, Inc. Common Stock | 163.09 Million USD | -1180.574% |
| AN2 Therapeutics, Inc. | 138.74 Million USD | -1405.356% |
| Anixa Biosciences, Inc. | 25.52 Million USD | -8083.493% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | 90.811% |
| Denali Therapeutics Inc. | 1.15 Billion USD | -81.0% |
| Revelation Biosciences, Inc. | 12.21 Million USD | -17001.923% |
| Veru Inc. | 50.59 Million USD | -4027.983% |
| Corvus Pharmaceuticals, Inc. | 45.55 Million USD | -4484.969% |
| Cingulate Inc. | 3.49 Million USD | -59720.401% |
| Passage Bio, Inc. | 150.54 Million USD | -1287.353% |
| Context Therapeutics Inc. | 16.06 Million USD | -12902.711% |
| Exicure, Inc. | 11.58 Million USD | -17936.192% |
| Day One Biopharmaceuticals, Inc. | 376.04 Million USD | -455.405% |
| Oramed Pharmaceuticals Inc. | 161.64 Million USD | -1192.109% |
| Scinai Immunotherapeutics Ltd. | 17.47 Million USD | -11853.932% |
| Rhythm Pharmaceuticals, Inc. | 332.74 Million USD | -527.685% |
| Nuvalent, Inc. | 732.38 Million USD | -185.177% |
| ABVC BioPharma, Inc. | 14.94 Million USD | -13876.044% |
| Carisma Therapeutics, Inc. | 89.55 Million USD | -2232.214% |
| Unicycive Therapeutics, Inc. | 14.19 Million USD | -14617.715% |
| OmniAb, Inc. | 401.98 Million USD | -419.569% |
| Anew Medical, Inc. | 19.45 Million USD | -10634.971% |
| Fennec Pharmaceuticals Inc. | 26.72 Million USD | -7714.666% |
| Lipocine Inc. | 23 Million USD | -8980.407% |
| Lexeo Therapeutics, Inc. Common Stock | 139.8 Million USD | -1393.91% |
| Nautilus Biotechnology, Inc. | 305.56 Million USD | -583.518% |
| SAB Biotherapeutics, Inc. | 83.94 Million USD | -2388.158% |
| G1 Therapeutics, Inc. | 121.54 Million USD | -1618.439% |
| Bellerophon Therapeutics, Inc. | 7.93 Million USD | -26221.248% |
| Sage Therapeutics, Inc. | 882.27 Million USD | -136.727% |
| Ocugen, Inc. | 64.54 Million USD | -3135.768% |
| Mind Medicine (MindMed) Inc. | 124.54 Million USD | -1577.031% |
| Q32 Bio Inc. | 306.11 Million USD | -582.281% |
| Brainstorm Cell Therapeutics Inc. | 4.2 Million USD | -49533.817% |
| Alumis Inc. Common Stock | 89.61 Million USD | -2230.705% |
| Equillium, Inc. | 50.53 Million USD | -4033.368% |
| Kyverna Therapeutics, Inc. | 75.19 Million USD | -2677.566% |
| Coya Therapeutics, Inc. | 41.27 Million USD | -4960.365% |
| CNS Pharmaceuticals, Inc. | 1.7 Million USD | -122696.679% |
| Galera Therapeutics, Inc. | 26.14 Million USD | -7889.713% |
| Evelo Biosciences, Inc. | 64.44 Million USD | -3141.09% |
| Comera Life Sciences Holdings, Inc. | 3.72 Million USD | -55937.77% |
| Dominari Holdings Inc. | 57.55 Million USD | -3528.672% |
| Edesa Biotech, Inc. | 8.89 Million USD | -23392.557% |
| vTv Therapeutics Inc. | 11.01 Million USD | -18856.172% |
| Bio-Techne Corporation | 2.81 Billion USD | 25.757% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -122.874% |
| Harmony Biosciences Holdings, Inc. | 811.44 Million USD | -157.391% |
| Prelude Therapeutics Incorporated | 277.66 Million USD | -652.198% |
| Candel Therapeutics, Inc. | 41.7 Million USD | -4908.371% |
| iTeos Therapeutics, Inc. | 667.58 Million USD | -212.856% |
| Nkarta, Inc. | 378.88 Million USD | -451.247% |
| BioCardia, Inc. | 2.98 Million USD | -69822.698% |
| Iterum Therapeutics plc | 26.25 Million USD | -7853.81% |